ACOR Market Cap History
Below is a table of the ACOR market cap history going back to 2/19/2010:

Date ACOR Market Cap
2/19/20101.21B
4/30/20101.50B
7/31/20101.26B
10/31/20101.06B
2/17/2011859.84M
4/30/20111.11B
7/31/20111.13B
10/31/2011866.34M
2/15/20121.05B
4/30/20121.01B
7/31/2012965.05M
10/31/2012961.78M
2/15/20131.20B
4/30/20131.61B
7/31/20131.55B
10/31/20131.26B
2/14/20141.37B
4/30/20141.48B
7/31/20141.22B
10/31/20141.46B
2/17/20151.59B
4/30/20151.29B
7/31/20151.47B
10/31/20151.56B
2/17/20161.64B
4/30/20161.19B
7/29/20161.17B
10/31/2016816.22M
2/17/20171.17B
4/30/2017753.55M
7/31/20171.01B
10/31/20171.24B
2/20/20181.19B
5/7/20181.10B
7/31/20181.18B
10/31/2018908.84M
2/20/2019624.00M
5/1/2019483.70M
7/31/2019333.39M
10/31/201979.25M
2/20/202075.36M

Also see: ACOR Shares Outstanding History
and ACOR YTD Return
ACOR Historical Market Cap:
-24.22% CAGR
ACOR Historical Market Cap: +-24.22% CAGR

Mouse over chart for data details
2/19/2010 ...2/20/2020
Acorda Therapeutics is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Co. is engaged in the commercial sales of Inbrija (levodopa inhalation powder), which is approved for intermittent treatment of OFF episodes, also known as OFF periods, in people with Parkinson's disease treated with carbidopa/levodopa. Also, Co. markets branded Ampyra (dalfampridine), an extended release tablet formulation of dalfampridine (4-aminopyridine, 4-AP) approved to improve walking in adults with multiple sclerosis. We show 41 historical shares outstanding datapoints in our ACOR shares outstanding history coverage, used to compute ACOR market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ACOR market cap history over the course of time is important for investors interested in comparing ACOR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ACOR versus a peer is one thing; comparing ACOR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ACOR can fluctuate over the course of history. With this page we aim to empower investors researching ACOR by allowing them to research the ACOR market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ACOR:
ACOR SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Acorda Therapeutics (ACOR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ACRS Market Cap History
ACRX Market Cap History
ACST Market Cap History
ADMA Market Cap History
ADMP Market Cap History
ADMS Market Cap History
ADPT Market Cap History
ADRO Market Cap History
ADUS Market Cap History
ADVM Market Cap History
More Healthcare companies »

 

ACOR Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.